FIELD: medicine, toxicology.
SUBSTANCE: the present innovation deals with the ways to inhibit toxins in animals and people in case of gastro-intestinal tract (GIT) disease. One should introduce therapeutically efficient quantity of polymer that has several lateral acidic functional groups attached directly to the main chain of polymer or being connected with it due to intermediate group. The latter could have the chain of 0-20 atoms length. Toxin is usually being exotoxin secreted by pathogenic microorganisms, such as bacteria, for example in case of diarrhea. The method enables to widen the quantity of preparations applied in case of bacterial GIT lesions.
EFFECT: higher efficiency.
39 cl, 2 dwg, 23 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTING GASTROINTESTINAL DISEASES IN ANIMALS OR PEOPLE, METHOD OF TREATING GASTROINTESTINAL DISEASES IN ANIMALS OR PEOPLE AND MEDICATION FOR TREATMENT OR PREVENTION OF GASTROINTESTINAL DISEASES IN ANIMALS OR PEOPLE | 2006 |
|
RU2412241C2 |
| ANTIBACTERIAL COMPOUNDS | 2009 |
|
RU2525915C2 |
| COMPOUNDS FOR TREATING CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES | 2011 |
|
RU2575477C2 |
| METHODS FOR TREATMENT AND PREVENTION OF C. DIFFICILE INFECTION | 2017 |
|
RU2751509C1 |
| 5-HYDROXYMETHYLOXAZOLIN-2-ONE DERIVATIVES FOR TREATING BACTERIAL INTESTINAL DISEASES | 2009 |
|
RU2527769C2 |
| TREATMENT OF BACTERIAL INFECTIONS | 2005 |
|
RU2377251C2 |
| NOVEL ANTIBACTERIAL MEDICATIONS FOR TREATMENT OF GRAM-POSITIVE INFECTIONS | 2009 |
|
RU2512396C2 |
| ANTIBODIES FOR TREATMENT OF INFECTION AND DISEASES ASSOCIATED WITH CLOSTRIDIUM DIFFICILE | 2011 |
|
RU2630663C9 |
| METHOD FOR TREATMENT OF HUMAN DISEASES CAUSED BY GRAM-POSITIVE BACTERIA | 2017 |
|
RU2661613C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING POLYMER BINDING SUBSTANCES WITH NONHYDROLYSED COVALENT LINKS, AND APPLICATION OF SAID COMPOSITIONS FOR CELIAC DISEASE | 2006 |
|
RU2453318C2 |
